US
Utsav Sanjaybhai Patel
About Utsav Sanjaybhai Patel
Data last updated:
Utsav Sanjaybhai Patel has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Actofi Pharma And Research Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Actofi Pharma And Research Private Limited at ₹1.35 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Actofi Pharma And Research Private Limited U24239GJ2021PTC123068 | Director | 03 Jun 2021 | 2021 | ₹1.35 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Utsav Sanjaybhai Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Utsav Sanjaybhai Patel
Utsav Sanjaybhai Patel has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Actofi Pharma And Research Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Actofi Pharma And Research Private Limited at ₹1.35 Cr (FY 2025).
Utsav Sanjaybhai Patel is associated with 1 company as Director, including Actofi Pharma And Research Private Limited (₹1.35 Cr).
Utsav Sanjaybhai Patel has expertise in General Business.
Utsav Sanjaybhai Patel has 5 years in corporate governance.
By reported revenue, the largest current company of Utsav Sanjaybhai Patel is Actofi Pharma And Research Private Limited, with revenue of ₹1.35 Cr (FY 2025).
Utsav Sanjaybhai Patel currently holds positions at 1 company: Actofi Pharma And Research Private Limited (₹1.35 Cr).